Clinical Trial: Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Assessment of Potential Interactions Between Intravenous Methamphetamine and Oral Selegiline
Brief Summary: The purpose of this study is to assess the potential interactions between intravenous methamphetamine and oral selegiline.
Detailed Summary: To determine the safety of the selegiline concurrent with d-methamphetamine challenges of 15mg & 30mg i.v. with the focus being on cardiovascular responses (HR,BP) to the i.v. methamphetamine challenges. This is a randomized, single-blind, placebo-controlled, two-arm study design to evaluate the safety of selegiline treatment, compared to placebo treatment, concurrent with i.v. methamphetamine challenges.
Sponsor: National Institute on Drug Abuse (NIDA)
Current Primary Outcome:
- safety of selegiline
- pharmacokinetic assessment
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: National Institute on Drug Abuse (NIDA)
Dates:
Date Received: April 5, 2002
Date Started: September 2001
Date Completion: October 2002
Last Updated: January 10, 2017
Last Verified: November 2003
